Kenly Sikwese
Lusaka, Zambia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Author Correction: Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa.
Journal: Nature communications
Published: April 17, 2026
Sustaining progress in HIV care in Africa with a transition to enabled self-care: a modelling study.
Sustaining progress in HIV care in Africa with a transition to enabled self-care: a modelling study.
Journal: The Lancet. Global health
Published: May 29, 2025
Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda.
Journal: AIDS and behavior
Published: July 01, 2024
The long wait for long-acting HIV prevention and treatment formulations.
Journal: The lancet. HIV
Published: March 23, 2024
Community-friendly diagnostics: Who are tests for?
Journal: PLOS global public health
Published: March 11, 2024
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.
Journal: The Lancet. Global health
Published: February 17, 2023
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
Journal: AIDS (London, England)
Published: July 25, 2022
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?
Journal: AIDS (London, England)
Published: December 01, 2021
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
Journal: Journal of the International AIDS Society
Published: April 29, 2019
Evolving Human Rights and the Science of Antiretroviral Medicine.
Journal: Health and human rights
Published: July 24, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026